GL1X · GenesisL1 explorer

MolNFT v1 · #163975 · protein + RNA

ZC3H12B-ribonuclease domain bound to RNA

6SJD · Probable ribonuclease ZC3H12B: “ZC3H12B-ribonuclease domain bound to RNA”. X-ray diffraction, 1 ligand (MG), 2 pockets (best druggability 0.68). MolNFT v1 #163975 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6SJD
Type
protein + RNA
Length
363 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Probable ribonuclease ZC3H12B; RNA (5'- R(*UP*GP*CP*GP*AP*CP*AP*GP*UP*CP*GP*GP*UP*AP*GP*CP…
EC
3.1.-.-
UniProt
Q5HYM0
Ligands
MG
Pockets
2 · best druggability 0.68

Structure

x-ray diffraction · 3 distinct chains · 36% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BProbable ribonuclease ZC3H12B (EC 3.1.-.-)protein16838% helix, 20% strandQ5HYM0
AProbable ribonuclease ZC3H12B (EC 3.1.-.-)protein17835% helix, 19% strandQ5HYM0
DRNA (5'- R(*UP*GP*CP*GP*AP*CP*AP*GP*UP*CP*GP*GP*UP*AP*GP*CP*A)-3')rna17——

Ligands and binding sites

  • MG · Magnesium ion · metal · 2 copies · chains B, D, A
  • CAC · Cacodylate ion · additive · chains D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16700.680.7746MG
22980.630.8044empty

Interfaces

2 interfaces between chains.

  • B–A · 1070 Ų buried · 9 hydrogen bonds · protein-protein
  • B–D · 458 Ų buried · 11 hydrogen bonds · protein-nucleic

Compared structures

  • 6SJD · ZC3H12B-ribonuclease domain bound to RNA · the same entry in another collection · chain B against B, TM-score 1.00
  • Q5HYM0 · AlphaFold monomer V2.0 prediction for probable ribonuclease ZC3H12B (Q5HYM0) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.